NEXGEL, Inc. (NXGL)

US — Healthcare Sector
Peers: GCTK  GMVD  POAI  PDEX  ZJYL  NYXH  DXR  MLSS  AVGR  STSS  LUCY 

Automate Your Wheel Strategy on NXGL

With Tiblio's Option Bot, you can configure your own wheel strategy including NXGL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol NXGL
  • Rev/Share 1.3377
  • Book/Share 0.7283
  • PB 3.2143
  • Debt/Equity 0.5074
  • CurrentRatio 1.8817
  • ROIC -0.4258

 

  • MktCap 16763436.0
  • FreeCF/Share -0.4533
  • PFCF -4.8365
  • PE -5.3322
  • Debt/Assets 0.2532
  • DivYield 0
  • ROE -0.6338

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 2
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

NEXGEL to Report First Quarter 2025 Financial Results on May 13th
NXGL
Published: May 09, 2025 by: GlobeNewsWire
Sentiment: Neutral

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa.

Read More
image for news NEXGEL to Report First Quarter 2025 Financial Results on May 13th
NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th
NXGL
Published: March 19, 2025 by: GlobeNewsWire
Sentiment: Neutral

Management will host a conference call at 4:30 p.m. ET on the same day LANGHORNE, Pa.

Read More
image for news NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th
NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025
NXGL
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral

LANGHORNE, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the Webull Consumer Virtual Webinar on February 18, 2025.

Read More
image for news NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025

About NEXGEL, Inc. (NXGL)

  • IPO Date 2021-12-22
  • Website https://nexgel.com
  • Industry Medical - Instruments & Supplies
  • CEO Mr. Adam R. Levy
  • Employees 19
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.